Clinical trial

Adipose Tissue After Switch to Doravirine

NCT05477407

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2022-10-06

PhaseNA

Study timeline

Study start (actual)2022-10-06Date precision: day

Registry last updated2025-01-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV Infectionsunresolved

Interventions

Switch from an INSTI-based regimen to the non INSTI-based regimen combining TDF/3TC/DoravirineDRUG

Sponsors & collaborators

Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sidalead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05477407 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.